Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis

D Fang, B Chen, A Lescoat, D Khanna… - Nature Reviews …, 2022 - nature.com
Systemic sclerosis (SSc) is a destructive connective tissue disease characterized by
dysregulation of the immune system and fibrosis in the skin and internal organs. The …

Current and emerging strategies to inhibit type 2 inflammation in atopic dermatitis

EB Haddad, SL Cyr, K Arima, RA McDonald… - Dermatology and …, 2022 - Springer
Type 2 immunity evolved to combat helminth infections by orchestrating a combined
protective response of innate and adaptive immune cells and promotion of parasitic worm …

Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis

F Ma, O Plazyo, AC Billi, LC Tsoi, X Xing… - Nature …, 2023 - nature.com
The immunopathogenesis of psoriasis, a common chronic inflammatory disease of the skin,
is incompletely understood. Here we demonstrate, using a combination of single cell and …

Elevated Fibronectin Levels in Profibrotic CD14+ Monocytes and CD14+ Macrophages in Systemic Sclerosis

M Rudnik, A Hukara, I Kocherova, S Jordan… - Frontiers in …, 2021 - frontiersin.org
Background Systemic sclerosis (SSc) is an autoimmune disease characterized by
overproduction of extracellular matrix (ECM) and multiorgan fibrosis. Animal studies pointed …

Advances in biological and targeted therapies for systemic sclerosis

E Mulcaire-Jones, AHL Low, R Domsic… - Expert Opinion on …, 2023 - Taylor & Francis
ABSTRACT Introduction Systemic sclerosis (SSc) is a severe, and often life-threatening,
autoimmune disease, which causes inflammation and fibrosis of the skin and internal …

Molecular features and stages of pulmonary fibrosis driven by type 2 inflammation

H Mattoo, DS Bangari, S Cummings… - American Journal of …, 2023 - atsjournals.org
Systemic sclerosis (SSc) is a progressive, multiorgan disease with limited treatment options.
Although a recent proof-of-concept study using romilkimab or SAR156597, a bispecific IL …

B cell depletion inhibits fibrosis via suppression of profibrotic macrophage differentiation in a mouse model of systemic sclerosis

H Numajiri, A Kuzumi, T Fukasawa… - Arthritis & …, 2021 - Wiley Online Library
Objective We undertook this study to investigate the effect of B cell depletion on fibrosis in
systemic sclerosis (SSc) and its mechanism of action. Methods Mice with bleomycin …

[HTML][HTML] PDGF promotes dermal fibroblast activation via a novel mechanism mediated by signaling through MCHR1

N Takamura, L Renaud, WA da Silveira… - Frontiers in …, 2021 - frontiersin.org
Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy and
excessive fibrosis of the skin and internal organs. To this day, no effective treatments to …

Semaphorin4A-plexin D1 axis induces Th2 and Th17 while represses Th1 skewing in an autocrine manner

T Carvalheiro, C Rafael-Vidal… - International Journal of …, 2020 - mdpi.com
Semaphorin (Sema) 4A is a transmembrane glycoprotein that is elevated in several
autoimmune diseases such as systemic sclerosis, rheumatoid arthritis and multiple …

Interrelationship and Sequencing of Interleukins4, 13, 31, and 33–An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives

AL Tatu, T Nadasdy, A Arbune, V Chioncel… - Journal of …, 2022 - Taylor & Francis
The interrelations and sequencing of interleukins are complex (inter) actions where each
interleukin can stimulate the secretion of its preceding interleukin. In this paper, we attempt …